|
CA1064396A
(en)
|
1975-02-18 |
1979-10-16 |
Myer L. Coval |
Fractional precipitation of gamma globulin with polyethylene glycol
|
|
US4075193A
(en)
|
1976-11-26 |
1978-02-21 |
Parke, Davis & Company |
Process for producing intravenous immune globulin
|
|
US4374763A
(en)
|
1979-09-17 |
1983-02-22 |
Morishita Pharmaceutical Co., Ltd. |
Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4499073A
(en)
|
1981-08-24 |
1985-02-12 |
Cutter Laboratories, Inc. |
Intravenously injectable immune serum globulin
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4597966A
(en)
|
1985-01-09 |
1986-07-01 |
Ortho Diagnostic Systems, Inc. |
Histidine stabilized immunoglobulin and method of preparation
|
|
US4966852A
(en)
|
1987-07-23 |
1990-10-30 |
Monsanto Company |
DNA clone of human tissue factor inhibitor
|
|
ATE82506T1
(de)
|
1987-08-21 |
1992-12-15 |
Imcera Group Inc |
Stabilisierung von wachstumshormonen.
|
|
US4877608A
(en)
|
1987-11-09 |
1989-10-31 |
Rorer Pharmaceutical Corporation |
Pharmaceutical plasma protein formulations in low ionic strength media
|
|
US5096885A
(en)
|
1988-04-15 |
1992-03-17 |
Genentech, Inc. |
Human growth hormone formulation
|
|
WO1989011297A1
(en)
|
1988-05-27 |
1989-11-30 |
Centocor, Inc. |
Freeze-dried formulation for antibody products
|
|
CA2049342A1
(en)
|
1989-03-27 |
1990-09-28 |
Sally Bolmer |
Formulations for stabilizing of igm antibodies
|
|
US6969586B1
(en)
|
1989-05-16 |
2005-11-29 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
|
US5217954A
(en)
|
1990-04-04 |
1993-06-08 |
Scios Nova Inc. |
Formulations for stabilizing fibroblast growth factor
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
DK261490D0
(da)
|
1990-10-31 |
1990-10-31 |
Novo Nordisk As |
New pharmaceutical compound
|
|
JPH0565233A
(ja)
|
1991-03-08 |
1993-03-19 |
Mitsui Toatsu Chem Inc |
モノクローナル抗体含有凍結乾燥製剤
|
|
US6165467A
(en)
|
1991-07-20 |
2000-12-26 |
Yoshihide Hagiwara |
Stabilized human monoclonal antibody preparation
|
|
GB9122820D0
(en)
|
1991-10-28 |
1991-12-11 |
Wellcome Found |
Stabilised antibodies
|
|
EP0539975A1
(en)
|
1991-10-31 |
1993-05-05 |
Teijin Limited |
Method for immunological assay of free lipoprotein-associated coagulation inhibitor (LACI) and kit therefor
|
|
US5849700A
(en)
|
1991-12-20 |
1998-12-15 |
Novo Nordisk A/S |
Pharmaceutical formulation
|
|
DE4223132A1
(de)
|
1992-07-14 |
1994-01-20 |
Deutsche Aerospace |
Verfahren zur Schrittakt-Regeneration bei der Demodulation von digital modulierten Signalen und Anordnung zum Ausführen des Verfahrens
|
|
JPH06153985A
(ja)
|
1992-11-16 |
1994-06-03 |
Teijin Ltd |
モノクローナル抗体
|
|
ATE197550T1
(de)
|
1993-02-23 |
2000-12-15 |
Genentech Inc |
Stabilisierung von mit organischen lösungsmittel behandelten polypeptiden mit einem hilfsstoff
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
DE4344824C1
(de)
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
|
US5580856A
(en)
|
1994-07-15 |
1996-12-03 |
Prestrelski; Steven J. |
Formulation of a reconstituted protein, and method and kit for the production thereof
|
|
JPH0875736A
(ja)
|
1994-09-06 |
1996-03-22 |
Chemo Sero Therapeut Res Inst |
ヒト組織因子凝固系インヒビターの定量法
|
|
GB9418092D0
(en)
|
1994-09-08 |
1994-10-26 |
Red Cross Found Cent Lab Blood |
Organic compounds
|
|
US6111079A
(en)
|
1995-06-05 |
2000-08-29 |
Bionebraska, Inc. |
Lead binding polypeptides and nucleotides coding therefore
|
|
WO1997004801A1
(en)
|
1995-07-27 |
1997-02-13 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US5902582A
(en)
|
1995-09-05 |
1999-05-11 |
Chiron Corporation |
Use of TFPI inhibitor for treatment of cancer
|
|
US6686191B1
(en)
|
1995-09-22 |
2004-02-03 |
Bayer Healthcare Llc |
Preparation of virally inactivated intravenously injectable immune serum globulin
|
|
JP3681206B2
(ja)
*
|
1995-12-26 |
2005-08-10 |
株式会社三菱化学ヤトロン |
抗ファクターＸａ・ティシュファクターパスウェイインヒビター複合体モノクローナル抗体及びその使用
|
|
DE59710863D1
(de)
|
1996-01-25 |
2003-11-20 |
Schering Ag |
Verbesserte kontrastmittenlösungen für die intravasale anwendung
|
|
US5770700A
(en)
|
1996-01-25 |
1998-06-23 |
Genetics Institute, Inc. |
Liquid factor IX formulations
|
|
KR100236393B1
(ko)
|
1996-02-02 |
1999-12-15 |
나까니시 히로유끼 |
사람성장호르몬을 함유하는 의약제제
|
|
TWI240627B
(en)
|
1996-04-26 |
2005-10-01 |
Chugai Pharmaceutical Co Ltd |
Erythropoietin solution preparation
|
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
|
US20040052799A1
(en)
|
1996-11-15 |
2004-03-18 |
Astra Aktiebolag |
Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
US6593291B1
(en)
|
1997-02-06 |
2003-07-15 |
Entremed, Inc. |
Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
|
|
DE69833545T2
(de)
|
1997-03-26 |
2006-12-14 |
Imperial College Innovations Ltd. |
In der zellmembran verankertes antikoagulant-fusionsprotein
|
|
US5994511A
(en)
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
|
US6531298B2
(en)
|
1997-07-21 |
2003-03-11 |
The University Of North Carolina At Chapel Hill |
Factor IX antihemophilic factor with increased clotting activity
|
|
US6617156B1
(en)
|
1997-08-15 |
2003-09-09 |
Lynn A. Doucette-Stamm |
Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
|
|
EP1005776B1
(de)
|
1997-08-21 |
2003-01-08 |
Siemens Aktiengesellschaft |
Verfahren zum übertragen von nutzdaten, die unterschiedlichen anwendungen zuordenbar sind
|
|
US6551795B1
(en)
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
|
AU3006799A
(en)
|
1998-03-12 |
1999-09-27 |
Human Genome Sciences, Inc. |
31 human secreted proteins
|
|
GB9820525D0
(en)
|
1998-09-21 |
1998-11-11 |
Allergy Therapeutics Ltd |
Formulation
|
|
US6818749B1
(en)
|
1998-10-31 |
2004-11-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Variants of humanized anti carcinoma monoclonal antibody cc49
|
|
JP2000247903A
(ja)
|
1999-03-01 |
2000-09-12 |
Chugai Pharmaceut Co Ltd |
長期安定化製剤
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
US20090087878A9
(en)
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
US20100293669A2
(en)
|
1999-05-06 |
2010-11-18 |
Jingdong Liu |
Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
WO2001024814A1
(en)
|
1999-10-04 |
2001-04-12 |
Chiron Corporation |
Stabilized liquid polypeptide-containing pharmaceutical compositions
|
|
US20050208558A1
(en)
|
1999-10-19 |
2005-09-22 |
Applera Corporation |
Detection kits, such as nucleic acid arrays, for detecting the expression or 10,000 or more Drosophila genes and uses thereof
|
|
JP4623825B2
(ja)
|
1999-12-16 |
2011-02-02 |
協和発酵バイオ株式会社 |
新規ポリヌクレオチド
|
|
US20020160934A1
(en)
|
2000-01-14 |
2002-10-31 |
Julie Broadus |
Nucleic acid sequences from Drosophila melanogaster that encode proteins essential for larval viability and uses thereof
|
|
US20030232054A1
(en)
|
2000-01-25 |
2003-12-18 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
|
JP4683810B2
(ja)
|
2000-02-29 |
2011-05-18 |
中外製薬株式会社 |
長期安定化製剤
|
|
ATE363915T1
(de)
|
2000-04-07 |
2007-06-15 |
Signal Coordinating Therapy In |
Methoden und zusammensetzungen zur behandlung von neoplasmen
|
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
US7834146B2
(en)
|
2000-05-08 |
2010-11-16 |
Monsanto Technology Llc |
Recombinant polypeptides associated with plants
|
|
US20040181830A1
(en)
|
2001-05-07 |
2004-09-16 |
Kovalic David K. |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
US20020082206A1
(en)
|
2000-05-30 |
2002-06-27 |
Leach Martin D. |
Novel polynucleotides from atherogenic cells and polypeptides encoded thereby
|
|
ES2609583T3
(es)
|
2000-06-16 |
2017-04-21 |
Human Genome Sciences, Inc. |
Anticuerpos que se unen inmunoespecíficamente a BLyS
|
|
JP5490972B2
(ja)
|
2000-08-04 |
2014-05-14 |
中外製薬株式会社 |
タンパク質注射製剤
|
|
DK1314437T3
(da)
|
2000-08-11 |
2014-07-14 |
Chugai Pharmaceutical Co Ltd |
Stabiliserede antistofindeholdende præparater
|
|
WO2002017957A1
(en)
|
2000-09-01 |
2002-03-07 |
Chugai Seiyaku Kabushiki Kaisha |
Solution preparations stabilized over long time
|
|
CA2423227C
(en)
|
2000-10-12 |
2011-11-29 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
US6912470B2
(en)
|
2001-05-21 |
2005-06-28 |
Ecopia Biosciences, Inc. |
Genes and proteins involved in the biosynthesis of enediyne ring structures
|
|
US7214786B2
(en)
|
2000-12-14 |
2007-05-08 |
Kovalic David K |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
GB0101879D0
(en)
|
2001-01-24 |
2001-03-07 |
Enzyme Res Lab Ltd |
Anticoagulants and their uses
|
|
CA2434323A1
(en)
|
2001-02-07 |
2002-11-28 |
Centre National De La Recherche Scientifique (Cnrs) |
Sequence of the photorhabdus luminescens strain tt01 genome and uses
|
|
GB0103424D0
(en)
|
2001-02-12 |
2001-03-28 |
Chiron Spa |
Gonococcus proteins
|
|
US7667004B2
(en)
*
|
2001-04-17 |
2010-02-23 |
Abmaxis, Inc. |
Humanized antibodies against vascular endothelial growth factor
|
|
US6891085B2
(en)
|
2001-04-20 |
2005-05-10 |
Pioneer Hi-Bred International, Inc. |
Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant
|
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
|
US20030113316A1
(en)
|
2001-07-25 |
2003-06-19 |
Kaisheva Elizabet A. |
Stable lyophilized pharmaceutical formulation of IgG antibodies
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
MXPA04003640A
(es)
|
2001-10-16 |
2005-04-11 |
Rxkinetix Inc |
Formulaciones de proteina de alta concentracion y metodo de fabricacion.
|
|
US20040029129A1
(en)
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
|
WO2003037172A2
(en)
|
2001-11-01 |
2003-05-08 |
Gpc Biotech Inc. |
Endothelial-cell binding peptides for diagnosis and therapy
|
|
JP5290489B2
(ja)
|
2001-11-08 |
2013-09-18 |
アッヴィ・バイオセラピューティクス・インコーポレイテッド |
Ｉｇｇ抗体の安定な液体医薬製剤
|
|
EP1461353A4
(en)
|
2001-11-29 |
2006-05-03 |
Wyeth Corp |
OPEN READING FRAMES (ORF) OF BACTERIUM ALLOIOCOCCUS OTITIDIS ENCODING ANTIGENIC POLYPEPTIDES, IMUNOGENIC COMPOSITIONS, AND USES THEREOF
|
|
US20030138416A1
(en)
|
2001-12-03 |
2003-07-24 |
Jesper Lau |
Use of glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
|
|
US20050108791A1
(en)
|
2001-12-04 |
2005-05-19 |
Edgerton Michael D. |
Transgenic plants with improved phenotypes
|
|
US7452539B2
(en)
|
2001-12-19 |
2008-11-18 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
|
AU2003225535A1
(en)
|
2002-01-31 |
2003-09-02 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cancer
|
|
KR20110091822A
(ko)
|
2002-02-14 |
2011-08-12 |
추가이 세이야쿠 가부시키가이샤 |
항체함유 용액제제
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
SI1946776T1
(sl)
|
2002-02-27 |
2017-07-31 |
Immunex Corporation |
Stabiliziran tnfr-fc sestavek, ki obsega arginin
|
|
US20060068386A1
(en)
|
2002-03-04 |
2006-03-30 |
Alexei Slesarev |
Complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
|
|
US7074559B2
(en)
|
2002-03-06 |
2006-07-11 |
Refents of the University of Minnesota |
Mycobacterial diagnostics
|
|
IL149820A0
(en)
|
2002-05-23 |
2002-11-10 |
Curetech Ltd |
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
|
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
US20040022792A1
(en)
|
2002-06-17 |
2004-02-05 |
Ralph Klinke |
Method of stabilizing proteins at low pH
|
|
JP2005530845A
(ja)
|
2002-06-21 |
2005-10-13 |
アイデック ファーマシューティカルズ コーポレイション |
抗体を濃縮するための緩衝化処方物およびその使用方法
|
|
AU2003256299A1
(en)
|
2002-07-01 |
2004-01-19 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to reg iv
|
|
EP1539212A4
(en)
|
2002-07-12 |
2007-05-02 |
Medarex Inc |
METHOD AND COMPOSITIONS FOR PREVENTING OXIDATIVE DEGRADATION OF PROTEINS
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
DE10239073A1
(de)
|
2002-08-26 |
2004-03-11 |
Basf Ag |
Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien
|
|
SI1556083T1
(sl)
|
2002-10-08 |
2011-05-31 |
Rinat Neuroscience Corp |
Postopki za zdravljenje postoperativne bolečine z dajanjem protitelesa proti živčnemu rastnemu faktorju in sestavki, ki ga vsebujejo
|
|
KR100542401B1
(ko)
|
2002-10-23 |
2006-01-11 |
한국전자통신연구원 |
인터넷 차별 서비스 망에서의 연결 수락 제어방법
|
|
WO2004050850A2
(en)
|
2002-12-02 |
2004-06-17 |
Abgenix, Inc. |
Antibodies directed to phospholipase a2 and uses thereof
|
|
WO2004055164A2
(en)
|
2002-12-13 |
2004-07-01 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
|
AU2003299898B2
(en)
|
2002-12-24 |
2010-12-16 |
Rinat Neuroscience Corp. |
Anti-NGF antibodies and methods using same
|
|
EP2853593B1
(en)
|
2003-03-07 |
2017-10-04 |
DSM IP Assets B.V. |
Hydrolases, nucleic acids encoding them and mehods for making and using them
|
|
US20050158303A1
(en)
|
2003-04-04 |
2005-07-21 |
Genentech, Inc. |
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
|
ZA200507757B
(en)
|
2003-04-04 |
2007-01-31 |
Genentech Inc |
High concentration antibody and protein formulations
|
|
CN1930187B
(zh)
*
|
2003-06-27 |
2015-08-19 |
艾默根佛蒙特有限公司 |
针对表皮生长因子受体的缺失突变体的抗体及其使用
|
|
PL1648509T3
(pl)
|
2003-07-15 |
2013-02-28 |
Amgen Inc |
Ludzkie neutralizujące przeciwciała anty-NGF jako selektywne inhibitory szlaku NGF
|
|
CN103880955A
(zh)
|
2003-07-18 |
2014-06-25 |
安姆根有限公司 |
肝细胞生长因子的特异性结合物
|
|
US7871610B2
(en)
|
2003-08-12 |
2011-01-18 |
Dyax Corp. |
Antibodies to Tie1 ectodomain
|
|
US20060107345A1
(en)
|
2003-09-30 |
2006-05-18 |
Nickolai Alexandrov |
Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
|
|
WO2005033143A1
(ja)
|
2003-10-01 |
2005-04-14 |
Kyowa Hakko Kogyo Co., Ltd. |
抗体の安定化方法及び安定化された溶液状抗体製剤
|
|
CA2445743A1
(en)
|
2003-10-08 |
2005-04-08 |
The University Of British Columbia |
Methods for modulating neuronal responses
|
|
EP1532983A1
(en)
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
|
DE602004026474D1
(de)
|
2003-12-03 |
2010-05-20 |
Univ Rochester |
Rekombinanter faktor viii mit erhöhter spezifischer aktivität
|
|
JPWO2005063291A1
(ja)
|
2003-12-25 |
2007-07-19 |
麒麟麦酒株式会社 |
抗体を含有する安定な水性医薬製剤
|
|
US7494798B2
(en)
|
2004-01-09 |
2009-02-24 |
Novozymes, Inc. |
Bacillus licheniformis chromosome
|
|
US20060041961A1
(en)
|
2004-03-25 |
2006-02-23 |
Abad Mark S |
Genes and uses for pant improvement
|
|
BRPI0511479C1
(pt)
|
2004-05-27 |
2021-05-25 |
Crucell Holland Bv |
molécula de ligação tendo atividade neutralizadora do vìrus da raiva, variante funcional de uma molécula de ligação, imunoconjugado, molécula de ácido nucléico, vetor, hospedeiro, método para produzir uma molécula de ligação ou uma variante funcional, composição farmacêutica, uso de uma molécula de ligação, uma variante funcional, um imunoconjugado como, ou uma composição, kit, método para identificar uma molécula de ligação ou uma molécula de ácido nucléico, e, coleção de moléculas de ligação humanas na superfìcie de pacotes genéticos replicáveis
|
|
CA2564791A1
(en)
|
2004-06-14 |
2005-12-29 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
|
CA2573293A1
(en)
|
2004-07-10 |
2006-02-16 |
Alexion Pharmaceuticals, Inc. |
Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby
|
|
US20080008719A1
(en)
|
2004-07-10 |
2008-01-10 |
Bowdish Katherine S |
Methods and compositions for the treatment of prostate cancer
|
|
US20060075522A1
(en)
|
2004-07-31 |
2006-04-06 |
Jaclyn Cleveland |
Genes and uses for plant improvement
|
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
PL1838733T3
(pl)
|
2004-12-21 |
2012-02-29 |
Medimmune Ltd |
Przeciwciała skierowane przeciwko angiopoetynie-2 i ich zastosowania
|
|
US20080148432A1
(en)
|
2005-12-21 |
2008-06-19 |
Mark Scott Abad |
Transgenic plants with enhanced agronomic traits
|
|
US7566772B2
(en)
|
2005-01-26 |
2009-07-28 |
Amgen Fremont Inc. |
Antibodies against interleukin-1β
|
|
PT1848744E
(pt)
|
2005-01-27 |
2012-04-24 |
Novimmune Sa |
Anticorpos anti-interferão gama e os seus processos de utilização
|
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
DOP2006000022A
(es)
|
2005-01-28 |
2006-08-15 |
Wyeth Corp |
Formulaciones líquidas estabilizadas de polipetidos
|
|
PT1850873T
(pt)
|
2005-02-08 |
2019-02-19 |
Genzyme Corp |
Anticorpos contra tgfbeta
|
|
US8088976B2
(en)
|
2005-02-24 |
2012-01-03 |
Monsanto Technology Llc |
Methods for genetic control of plant pest infestation and compositions thereof
|
|
AU2006219823A1
(en)
|
2005-03-02 |
2006-09-08 |
Metanomics Gmbh |
Process for the production of fine chemicals
|
|
JP2008531692A
(ja)
|
2005-03-04 |
2008-08-14 |
ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ |
凝固及び線維素溶解カスケードのモジュレーター
|
|
PL2620450T3
(pl)
|
2005-03-08 |
2019-05-31 |
Pfizer Prod Inc |
Kompozycje przeciwciała anty-CTLA-4
|
|
JP2006249082A
(ja)
|
2005-03-08 |
2006-09-21 |
Pharmacia & Upjohn Co Llc |
低減レベルの内毒素を有する抗ｍ−ｃｓｆ抗体組成物
|
|
US7785595B2
(en)
|
2005-04-18 |
2010-08-31 |
Yeda Research And Development Company Limited |
Stabilized anti-hepatitis B (HBV) antibody formulations
|
|
US7889636B2
(en)
|
2005-05-24 |
2011-02-15 |
Cisco Technology, Inc. |
System and method for implementing a mid-call policy in a RSVP environment
|
|
GB2426887B
(en)
|
2005-06-04 |
2009-01-07 |
Ibm |
Client responsibilities in messaging systems
|
|
ATE501248T1
(de)
|
2005-07-02 |
2011-03-15 |
Arecor Ltd |
Stabile wässrige systeme mit proteinen
|
|
NZ599176A
(en)
|
2005-08-03 |
2014-04-30 |
Immunogen Inc |
Immunoconjugate formulations
|
|
AU2006295340B2
(en)
|
2005-08-05 |
2010-11-11 |
Amgen Inc. |
Stable aqueous protein or antibody pharmaceutical formulations and their preparation
|
|
US20070086433A1
(en)
|
2005-10-19 |
2007-04-19 |
Cunetto Philip C |
Methods and apparatus for allocating shared communication resources to outdial communication services
|
|
CN101360821A
(zh)
|
2005-11-21 |
2009-02-04 |
圣诺菲·帕斯图尔有限公司 |
重组病毒的稳定制剂
|
|
CA2631327C
(en)
|
2005-12-02 |
2015-10-13 |
Genentech, Inc. |
Her2 binding polypeptides and uses thereof
|
|
US7669228B2
(en)
|
2005-12-27 |
2010-02-23 |
Cisco Technology, Inc. |
System and method for changing network behavior based on presence information
|
|
WO2007074880A1
(ja)
|
2005-12-28 |
2007-07-05 |
Chugai Seiyaku Kabushiki Kaisha |
抗体含有安定化製剤
|
|
KR20080098504A
(ko)
|
2006-02-03 |
2008-11-10 |
메디뮨 엘엘씨 |
단백질 제제
|
|
DE102006005094A1
(de)
|
2006-02-04 |
2007-08-09 |
Degussa Gmbh |
Titandioxid und Polycarboxylatether enthaltende Dispersion
|
|
US7790862B2
(en)
|
2006-06-13 |
2010-09-07 |
Zymogenetics, Inc. |
IL-17 and IL-23 antagonists and methods of using the same
|
|
US20070224627A1
(en)
|
2006-03-23 |
2007-09-27 |
Lawrence Horowitz |
Facilitation of translocation of molecules through the gastrointestinal tract
|
|
EA200870538A1
(ru)
|
2006-06-14 |
2009-04-28 |
Имклоун Системз Инкорпорейтед |
Лиофилизированные композиции анти-egfr антител
|
|
ES2531933T3
(es)
|
2006-06-30 |
2015-03-20 |
Novo Nordisk A/S |
Anticuerpos anti-NKG2A y usos de los mismos
|
|
US8355333B2
(en)
|
2006-08-31 |
2013-01-15 |
Ciena Corporation |
Methods and systems for session initiation protocol control of network equipment
|
|
JP2010506839A
(ja)
|
2006-10-12 |
2010-03-04 |
ワイス エルエルシー |
乳光の低減を伴う方法および組成物
|
|
AU2007331712A1
(en)
|
2006-12-11 |
2008-06-19 |
F. Hoffmann-La Roche Ag |
Abeta antibody parenteral formulation
|
|
US20100209434A1
(en)
|
2007-03-30 |
2010-08-19 |
Medimmune, Llc |
Antibody formulation
|
|
GB0707938D0
(en)
|
2007-04-25 |
2007-05-30 |
Univ Strathclyde |
Precipitation stabilising compositions
|
|
TR201820837T4
(tr)
|
2007-06-14 |
2019-01-21 |
Biogen Ma Inc |
Natalizumab antikor formülasyonları.
|
|
UA107557C2
(xx)
|
2007-07-06 |
2015-01-26 |
|
Композиція антитіла офатумумабу
|
|
DK3002298T3
(da)
*
|
2007-11-21 |
2019-10-28 |
Univ Oregon Health & Science |
Anti-faktor xi monoklonale antistoffer og fremgangsmåder til anvendelse deraf
|
|
EP2225275A4
(en)
|
2007-11-28 |
2013-04-03 |
Medimmune Llc |
PROTEIN FORMULATION
|
|
DK2222706T4
(en)
|
2007-12-14 |
2016-11-21 |
Novo Nordisk As |
Antibodies that bind to NKG2D and its use
|
|
AU2008340429C1
(en)
|
2007-12-21 |
2016-09-08 |
F. Hoffmann-La Roche Ag |
Antibody formulation
|
|
WO2009083225A2
(en)
|
2007-12-28 |
2009-07-09 |
Biolnvent International Ab |
Formulation
|
|
KR20100117120A
(ko)
|
2008-02-20 |
2010-11-02 |
지투 인플레메이션 피티와이 엘티디 |
인간화된 항-Ｃ5ａＲ 항체
|
|
WO2009120684A1
(en)
|
2008-03-25 |
2009-10-01 |
Medimmune, Llc |
Antibody formulation
|
|
JP2011526591A
(ja)
|
2008-06-30 |
2011-10-13 |
ノボ・ノルデイスク・エー／エス |
抗ヒトインターロイキン−２０抗体
|
|
PL2331090T3
(pl)
|
2008-09-19 |
2018-05-30 |
Pfizer Inc. |
Stabilny ciekły preparat przeciwciała
|
|
CN102301235B
(zh)
|
2008-11-28 |
2014-11-19 |
Abbvie公司 |
稳定的抗体组合物和用于稳定其的方法
|
|
EP2196476A1
(en)
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
|
US8466108B2
(en)
|
2008-12-19 |
2013-06-18 |
Baxter International Inc. |
TFPI inhibitors and methods of use
|
|
US8618263B2
(en)
|
2008-12-22 |
2013-12-31 |
Novo Nordisk A/S |
Antibodies against tissue factor pathway inhibitor (TFPI)
|
|
JP5714505B2
(ja)
|
2008-12-22 |
2015-05-07 |
ノヴォ ノルディスク アー／エス |
組織因子経路阻害因子に対する抗体
|
|
AR076640A1
(es)
|
2009-03-06 |
2011-06-29 |
Genentech Inc |
Formulacion con anticuerpo. metodo para estabilizar anticuerpo. articulo de manufactura
|
|
WO2010148337A1
(en)
|
2009-06-18 |
2010-12-23 |
Wyeth Llc |
Lyophilized formulations for small modular immunopharmaceuticals
|
|
WO2011026945A1
(en)
|
2009-09-03 |
2011-03-10 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
EP2332995A1
(en)
|
2009-12-10 |
2011-06-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neutralizing prolactin receptor antibodies and their therapeutic use
|
|
JP2013520476A
(ja)
|
2010-02-26 |
2013-06-06 |
ノヴォ ノルディスク アー／エス |
安定な抗体含有組成物
|
|
CN110835373A
(zh)
*
|
2010-03-01 |
2020-02-25 |
拜耳医药保健有限公司 |
针对组织因子途径抑制剂(tfpi)的优化的单克隆抗体
|
|
AU2011227714B2
(en)
|
2010-03-19 |
2014-09-04 |
Takeda Pharmaceutical Company Limited |
TFPI inhibitors and methods of use
|
|
KR20130086144A
(ko)
|
2010-05-28 |
2013-07-31 |
노보 노르디스크 에이/에스 |
항체 및 보존제를 포함하는 안정한 다중-투여 조성물
|
|
EP2673364A1
(en)
|
2011-02-11 |
2013-12-18 |
Baxter International Inc |
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
|
|
EA034214B1
(ru)
|
2011-04-01 |
2020-01-17 |
Байер Хелфкеа Ллк |
Выделенное моноклональное антитело или его антигенсвязывающий фрагмент, который связывается с эпитопом ингибитора пути тканевого фактора человека, содержащая его фармацевтическая композиция, способ применения этой композиции и кодирующая антитело молекула нуклеиновой кислоты
|
|
AU2013235567A1
(en)
|
2012-03-22 |
2014-10-09 |
Baxalta GmbH |
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
|
|
US8613919B1
(en)
|
2012-08-31 |
2013-12-24 |
Bayer Healthcare, Llc |
High concentration antibody and protein formulations
|
|
US9592297B2
(en)
|
2012-08-31 |
2017-03-14 |
Bayer Healthcare Llc |
Antibody and protein formulations
|
|
HRP20180078T1
(hr)
|
2013-03-15 |
2018-03-09 |
Bayer Healthcare Llc |
VARIJANTE ANTI-TFPI PROTUTIJELA S DIFERENCIJALNIM VEZANJEM U ŠIROKOM RASPONU pH RADI POBOLJŠANE FARMAKOKINETIKE
|
|
EP4279128A3
(en)
|
2015-02-25 |
2024-02-28 |
Mogam Institute for Biomedical Research |
Novel antibody binding to tfpi and composition comprising the same
|
|
KR102068915B1
(ko)
|
2015-08-19 |
2020-01-22 |
화이자 인코포레이티드 |
조직 인자 경로 억제제 항체 및 그의 용도
|